Chinese researchers have started a second human trial phase on a possible coronavirus vaccine, the Medical Academy of Chinese Academy of Medical Sciences (IMBCAMS) Institute said on Sunday to further assess the efficiency and safety.
A dozen vaccines are in various stages of human testing around the world, as the World Health Organization warns that the coronavirus pandemic is accelerating and that “the world is in a new dangerous phase”.
However, none of the vaccine trials has successfully completed large-scale Phase 3 clinical trials, a necessary step before obtaining regulatory approval for sale.
IMBCAMS started a human phase 2 test on Saturday for its experimental shot, which is one of six possible vaccines that Chinese scientists are testing in humans, following an ongoing phase 1 study that recruited around 200 participants. since May, the institute said on Sunday. in his social media channel.
The phase 2 trial will determine the dose of the vaccine and will continue to assess whether the potential vaccine can safely trigger immune responses in healthy people.
IMBCAMS said it plans to use a factory dedicated to the production of a coronavirus vaccine this year to prepare for future vaccine supplies from China.
By the end of 2020, certain groups of people with special needs may use experimental vaccines in urgent circumstances, said Gao Fu, director of the China Center for Disease Control and Prevention last month.
The coronavirus, which was first detected in China in late 2019, infected 8.81 million people worldwide and killed more than 4.60,000 people.
(With the exception of the title, this story was not edited by GalacticGaming staff and is published from a syndicated feed.)